Is Buying Biocryst Pharmaceuticals Inc (NASDAQ:BCRX), Having Lower Short Interest a Winning ...

Retrieved on: 2018-03-18 23:33:45

Tags for this article:

Finance

Economy

NASDAQ

Short

Chemistry

BioCryst Pharmaceuticals

Peramivir

Forodesine

Click the tags to see associated articles and topics

Is Buying Biocryst Pharmaceuticals Inc (NASDAQ:BCRX), Having Lower Short Interest a Winning .... View article details on HISWAI:

Excerpt

<div><b>Aqr Capital Management</b> Limited Liability Com holds 66,119 shares or 0% of its portfolio. Pennsylvania-based Sei Investments Company has invested 0% in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). The stock of Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) registered a decrease of 10.43% in ...</div>

Article found on:

View Original Article